Freeman Kevin Lee
SEC CIK 1945797 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| HCAT | Health Catalyst, Inc. | Chief Growth Off | 358.7K | — | $170.2K | 20 | 2022-09-08 | 2025-12-01 |
Most active insiders at HCAT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Larson-Green Julie | Dir | — | $128.2K |
| 2 | Kohl Simeon | CEO, Dir | $105.4K | — |
| 3 | Landry Benjamin | GC | — | $72.4K |
| 4 | Albert Benjamin | Pres, COO | — | — |
| 5 | Hoggard Green Jill | Dir | — | — |
| 6 | Freeman Kevin Lee | Chief Commercial Off | — | — |
| 7 | Alger Jason | CFO | — | — |
| 8 | Burton Daniel D. | CEO, Dir | — | — |
| 9 | Gallagher Duncan | Dir | — | — |
| 10 | Llewelyn Linda | CHRO | — | — |
Transactions 20
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-03 | 2025-12-01 | HCAT | Health Catalyst, Inc. | Freeman Kevin Lee | Chief Commercial Off | F - Tax | $2.90 | -16.4K | 358.7K | -4% | -$47.6K | |
| 2025-09-04 | 2025-09-02 | HCAT | Health Catalyst, Inc. | Freeman Kevin Lee | Chief Commercial Off | F - Tax | $3.36 | -4,578 | 375.1K | -1% | -$15.4K | |
| 2025-06-03 | 2025-06-02 | HCAT | Health Catalyst, Inc. | Freeman Kevin Lee | Chief Commercial Off | F - Tax | $3.63 | -4,747 | 379.7K | -1% | -$17.2K | |
| 2025-03-04 | 2025-03-03 | HCAT | Health Catalyst, Inc. | Freeman Kevin Lee | Chief Commercial Off | F - Tax | $4.58 | -10.8K | 384.4K | -3% | -$49.5K | |
| M | 2025-02-24 | 2025-02-20 | HCAT | Health Catalyst, Inc. | Freeman Kevin Lee | Chief Commercial Off | A - Grant | $0.00 | +158.3K | 376.9K | +72% | $0 |
| 2024-12-03 | 2024-12-01 | HCAT | Health Catalyst, Inc. | Freeman Kevin Lee | Chief Commercial Off | F - Tax | $8.97 | -11.4K | 244.4K | -4% | -$102.5K | |
| 2024-12-03 | 2024-12-02 | HCAT | Health Catalyst, Inc. | Freeman Kevin Lee | Chief Commercial Off | S - Sale | $8.94 | -7,500 | 236.9K | -3% | -$67.0K | |
| 2024-09-05 | 2024-09-03 | HCAT | Health Catalyst, Inc. | Freeman Kevin Lee | Chief Commercial Off | F - Tax | $7.27 | -2,772 | 263.4K | -1% | -$20.2K | |
| 2024-09-05 | 2024-09-03 | HCAT | Health Catalyst, Inc. | Freeman Kevin Lee | Chief Commercial Off | S - Sale | $7.22 | -7,500 | 255.9K | -3% | -$54.1K | |
| T | 2024-06-12 | 2024-06-11 | HCAT | Health Catalyst, Inc. | Freeman Kevin Lee | Chief Commercial Off | S - Sale | $6.53 | -7,500 | 266.2K | -3% | -$49.0K |
| 2024-06-04 | 2024-06-03 | HCAT | Health Catalyst, Inc. | Freeman Kevin Lee | Chief Commercial Off | F - Tax | $6.53 | -2,951 | 273.7K | -1% | -$19.3K | |
| 2024-03-05 | 2024-03-01 | HCAT | Health Catalyst, Inc. | Freeman Kevin Lee | Chief Commercial Off | F - Tax | $8.05 | -4,540 | 276.6K | -2% | -$36.5K | |
| M | 2024-02-22 | 2024-02-20 | HCAT | Health Catalyst, Inc. | Freeman Kevin Lee | Chief Commercial Off | A - Grant | $0.00 | +113.3K | 281.1K | +68% | $0 |
| 2023-12-05 | 2023-12-01 | HCAT | Health Catalyst, Inc. | Freeman Kevin Lee | Chief Commercial Off | F - Tax | $7.45 | -2,921 | 167.8K | -2% | -$21.8K | |
| 2023-09-06 | 2023-09-01 | HCAT | Health Catalyst, Inc. | Freeman Kevin Lee | Chief Commercial Off | F - Tax | $11.78 | -8,460 | 170.7K | -5% | -$99.7K | |
| 2023-06-05 | 2023-06-01 | HCAT | Health Catalyst, Inc. | Freeman Kevin Lee | Chief Commercial Off | F - Tax | $11.24 | -1,038 | 179.2K | -0.6% | -$11.7K | |
| M | 2023-03-03 | 2023-03-01 | HCAT | Health Catalyst, Inc. | Freeman Kevin Lee | Chief Commercial Off | A - Grant | $0.00 | +3,083 | 180.9K | +2% | $0 |
| 2023-03-03 | 2023-03-01 | HCAT | Health Catalyst, Inc. | Freeman Kevin Lee | Chief Commercial Off | F - Tax | $14.29 | -1,569 | 177.8K | -0.9% | -$22.4K | |
| 2022-12-05 | 2022-12-01 | HCAT | Health Catalyst, Inc. | Freeman Kevin Lee | Chief Growth Off | F - Tax | $10.65 | -2,446 | 179.4K | -1% | -$26.0K | |
| 2022-09-12 | 2022-09-08 | HCAT | Health Catalyst, Inc. | Freeman Kevin Lee | Chief Growth Off | A - Grant | $0.00 | +120.0K | 181.9K | +194% | $0 |
Purchase Sale Sale after option exercise All abbreviations